Колоректальный рак

Associate Dean Clinical Operations

Chair

Department of Surgery

Drexel University College of Medicine

Philadelphia

PA

Раскрытие информации

DES declares that he has no competing interests.

Chief

Division of Colorectal Surgery

Department of Surgery

Drexel University

Philadelphia

PA

Раскрытие информации

JLP declares that he has no competing interests.

Assistant Professor of Medicine

Department of Surgery

Drexel University

Philadelphia

PA

Раскрытие информации

JR declares that he has no competing interests.

Dr David E. Stein, Dr Juan L. Poggio, and Dr Jascha Rubin would like to gratefully acknowledge Dr Najjia Mahmoud, Dr Emily Carter Paulson, Dr Gary Atkin, Dr Anne Ballinger, Dr Mark O'Hara, Dr Mark Harrison, and Dr Robert Glynne-Jones, previous contributors to this topic.

Раскрытие информации

NM, ECP, MOH, GA, and AB declare that they have no competing interests. MH is the chair of the Mount Vernon Upper GI Tumour Site Specific Group and a member of the National Cancer Research Institute anal, rectal, and advanced colorectal groups. He has also received honoraria for speaking and has been supported to attend international meetings in GI cancer from Roche. He has also received research funding from Pfizer for a trial in rectal cancer. RGJ is the chief medical adviser to the charity Bowel Cancer UK. He has received honoraria for lectures from Roche, Sanofi, and Pfizer. He has received funding for the EXTRA study, involving capecitabine and radiotherapy in anal cancer, published in the International Journal of Radiation Biology Physics. RGJ has also received funding and free cetuximab for an ongoing phase I/II study integrating cetuximab into chemoradiation in rectal cancer, and has an agreement from Roche to supply bevacizumab for 3 months to 60 patients in one randomised phase II study as neoadjuvant chemotherapy in rectal cancer (BACCHUS). He has also been supported by Roche to attend international meetings in GI cancer.